ArticleMaterials today. Bio2026
All-in-one nerve guidance: transplanting a gradient scaffold with immobilized Schwann cells for peripheral nerve regeneration.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripheral nerve injury (PNI), especially those with long-distance transected defects, remains a major clinical challenge due to limited regenerative capacity associated with inadequate endogenous Schwann cell (SC) support. Here, we developed a biomimetic nerve graft with a defined spatial gradient of immobilized SCs to facilitate effective transplantation and axonal guidance, thus enhancing peripheral nerve regeneration. SCs were initially encapsulated within decellularized nerve matrix (DNM) microgels using a customized flow-focusing microfluidic device. The DNM microgels supported good viability, facilitated cellular proliferation, and preserved the repair phenotype of the encapsulated SCs, while maintaining their advantageous paracrine activity conducive to axon extension. Furthermore, these microgels were incorporated into the density-gradient pores of a pre-designed scaffold, resulting in a gradient SC-laden scaffold, designated as MGs@G-scaffold. Notably, the spatially graded SCs within the MGs@G-scaffold created a stable environmental gradient of neurotrophic factors, thereby providing sustained biochemical cues to guide axonal elongation. Finally, when transplanted into a 15-mm rat sciatic nerve defect model, the SC-laden scaffolds exhibited significantly improved axonal regeneration, remyelination, and functional recovery compared with the SC-free scaffolds. Additionally, MGs@G-scaffolds outperformed scaffolds with uniform SC distribution (MGs@H-scaffolds), achieving therapeutic outcomes comparable to autografts. Overall, this study demonstrates that transplanting spatially graded SCs embedded in a tissue-engineered bioactive scaffold offers sustained ongoing support for cells, gradient biochemical signals, and a pro-regenerative microenvironment for nerve regeneration and functional recovery, which holds great promise for long-distance PNI repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.